FDA Approves Moderna’s mFLUSIVA, the First mRNA-Based Seasonal Influenza Vaccine
Moderna, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved mFLUSIVA (mRNA-1010), making it the first mRNA-based vaccine approved for seasonal influenza.
The vaccine...
Government Expands Anti-Drug Operations and Rehabilitation Network in Jammu & Kashmir
The Union Ministry of Social Justice and Empowerment has reaffirmed its commitment to combating substance abuse in Jammu & Kashmir by expanding regional rehabilitation...
Dr. Reddy’s Strengthens U.S. Portfolio with First Generic Sugammadex Injection Launch
Dr. Reddy’s Laboratories Ltd. has introduced SugammadexInjection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) single-dose vials, a generic equivalent of Merck's Bridion®,...
Government Sends Expert Task Force to Gujarat and Rajasthan for Chandipura Virus Outbreak
The Union Ministry of Health and Family Welfare has assigneda multidisciplinary National Joint Outbreak Response Team (NJORT) to Gujarat and Rajasthan to boost public health response measures...
Pathos AI Expands Oncology Pipeline Through Strategic Deals with Alphamab and AstraZeneca
Pathos AI announced two separate licensing and co-development agreements with Alphamab Oncology and AstraZeneca, expanding its clinical-stage pipeline of targeted cancer therapies using its proprietary platform,...
FSSAI Directs Dabur to Withdraw Some Food Products Carrying ‘100%’ Claims
The Food Safety and Standards Authority of India (FSSAI) has intensified its scrutiny of misleading food advertisements, particularly the use of absolute claims such...
